Cashu Markets
Cashu
Markets
  • Terminal
  • Spotlight
  • News
Log inSign Up
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. ERAS
EI

Erasca, Inc.

ERAS
NASDAQ (NASDAQ Global Select)USD
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Markets
Cashu
Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

Company

About Cashu MarketsContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

News

Erasca's Legal Challenges and Market Response

Erasca's Legal Challenges and Market Response

Erasca, Inc. ( ERAS ) is a biotechnology company specializing in precision oncology and has attracted considerable attention for its innovative approaches to treating cancer. However, recent events su…

Cashu Markets·3h ago

Clear Street Enhances Biotechnology Research Focus, Highlighting Erasca Investment Insights

Clear Street Expands Equity Research into Biotechnology Sector Clear Street, a cloud-native financial technology firm, is set to enhance its equity research capabilities by focusing on the healthcare…

Cashu Markets·over 1 year ago

Erasca: Taylor Swift's Eras Tour Redefines Engagement in the Entertainment Industry

Eras Tour: A Blueprint for Innovation in the Entertainment Industry Taylor Swift’s Eras Tour sets a new benchmark in the entertainment sector, accumulating over $2 billion in revenues over 21 months t…

Cashu Markets·over 1 year ago